Literature DB >> 16627593

Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy.

Matthew E Falagas1, Sofia K Kasiakou, Petros I Rafailidis, George Zouglakis, Panayiota Morfou.   

Abstract

OBJECTIVES: To evaluate the effect of inappropriate empirical antimicrobial treatment on the mortality of patients with Acinetobacter baumannii bacteraemia.
METHODS: Retrospective cohort study of patients with A. baumannii bacteraemia hospitalized at the Henry Dunant hospital from January 2002 to December 2004.
RESULTS: Among 40 patients with A. baumannii bacteraemia, 22 (55%) and 18 (45%) received inappropriate and appropriate antibiotic therapy, respectively, during the 3 day period after obtaining the blood culture(s) from which the pathogen was isolated. Failure to cure the infection was more common in the first group [16/22 patients (72.7%) versus 5/18 (27.8%), P = 0.005]. Although without statistical significance, probably due to the small number of studied patients, considerably increased mortality was noted in the first group compared with the second group [13/22 patients (59.1%) versus 6/18 (33.3%), P = 0.10].
CONCLUSIONS: A. baumannii bacteraemia was associated with worse outcome regarding the cure of infection in patients who received inappropriate empirical antimicrobial treatment compared with those who received appropriate treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16627593     DOI: 10.1093/jac/dkl130

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  38 in total

Review 1.  Antimicrobial resistance in hospital-acquired gram-negative bacterial infections.

Authors:  Borna Mehrad; Nina M Clark; George G Zhanel; Joseph P Lynch
Journal:  Chest       Date:  2015-05       Impact factor: 9.410

2.  Epidemiology of Acinetobacter spp.-associated healthcare infections and colonization among children at a tertiary-care hospital in Saudi Arabia: a 6-year retrospective cohort study.

Authors:  H H Balkhy; M S Bawazeer; R F Kattan; H M Tamim; S M Al Johani; F A Aldughashem; H A Al Alem; A Adlan; L A Herwaldt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-04-05       Impact factor: 3.267

3.  Fast assessment of resistance to carbapenems and ciprofloxacin of clinical strains of Acinetobacter baumannii.

Authors:  Germán Bou; Fátima María Otero; Rebeca Santiso; María Tamayo; María del Carmen Fernández; María Tomás; Jaime Gosálvez; José Luis Fernández
Journal:  J Clin Microbiol       Date:  2012-08-29       Impact factor: 5.948

4.  Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections.

Authors:  John S Esterly; Milena Griffith; Chao Qi; Michael Malczynski; Michael J Postelnick; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2011-08-08       Impact factor: 5.191

5.  Rapid determination of quinolone resistance in Acinetobacter spp.

Authors:  Kristine M Hujer; Andrea M Hujer; Andrea Endimiani; Jodi M Thomson; Mark D Adams; Karrie Goglin; Philip N Rather; Thuy-Trang D Pennella; Christian Massire; Mark W Eshoo; Rangarajan Sampath; Lawrence B Blyn; David J Ecker; Robert A Bonomo
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948

Review 6.  Acinetobacter baumannii-associated skin and soft tissue infections: recognizing a broadening spectrum of disease.

Authors:  Dubert M Guerrero; Federico Perez; Nicholas G Conger; Joseph S Solomkin; Mark D Adams; Philip N Rather; Robert A Bonomo
Journal:  Surg Infect (Larchmt)       Date:  2010-02       Impact factor: 2.150

7.  Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance.

Authors:  D W Wareham; D C Bean; P Khanna; E M Hennessy; D Krahe; A Ely; M Millar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-02-19       Impact factor: 3.267

Review 8.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 9.  Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence.

Authors:  Drosos E Karageorgopoulos; Theodore Kelesidis; Iosif Kelesidis; Matthew E Falagas
Journal:  J Antimicrob Chemother       Date:  2008-04-24       Impact factor: 5.790

10.  Rapid determination of colistin resistance in clinical strains of Acinetobacter baumannii by use of the micromax assay.

Authors:  Maria Tamayo; Rebeca Santiso; Fátima Otero; Germán Bou; José Antonio Lepe; Michael J McConnell; José Miguel Cisneros; Jaime Gosálvez; José Luis Fernández
Journal:  J Clin Microbiol       Date:  2013-08-28       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.